We found those mRNA vaccines induced neutralizing antibodies in a greater proportion of pregnant individuals than did the Ad26.COV2.S vaccine, although this difference did not reach statistical significance (52% (13/25) for mRNA-1273, 35% (12/34) for BNT162b2, 18% (2/11) for Ad26.COV2.S, p = 0.13, Fig.
← all excerpts
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms.
1
0.1300
0.1300